Triple-gene therapy for stroke: A proof-of-concept in vivo study in rats-nuclear cells (UCB-MC) transduced with 
adenoviral vectors carrying genes encoding vascular endothelial growth
 Development of vaccines based on adenoviral vectors: A review of foreign clinical studies (Part 1) dissemination. Recent promising developments include genetically engineered vaccines based on 
adenoviral vectors Preventive triple gene therapy reduces the negative consequences of ischemia-induced brain injury after modelling stroke in a ratMarkosyan V., 
Safiullov Z., 
Izmailov A., 
Fadeev F., 
Sokolov M., 
Kuznetsov M., 
Trofimov D., 
Kim E., 
Kundakchyan G., 
Gibadullin A., 
Salafutdinov I., 
Nurullin L., 
Bashirov F., 
Islamov R.  therapy for stroke. 
Adenoviral vectors carrying genes encoding vascular endothelial growth factor (VEGF
 Effect of Adenoviral Transduction of Hepatic Stellate Cells with Adv5-optHGF-RFP on their Phenotype) with 
adenoviral vector containing genes of hepatocytes growth factor (HGF) and red fluorescent protein (RFP) as a